Mouse monoclonal antibodies against human c-Mpl and characterization for flow cytometry applications

Hybridoma

Volumn 29, Issue 2, 2010, Pages 103-113

  Abbott, Christina ^a   Huang, Guo ^a   Ellison, Aaron R ^a   Chen, Ching ^a   Arora, Taruna ^a   Szilvassy, Stephen J ^a   Wei, Ping ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTEIN C MPL; UNCLASSIFIED DRUG; MPL PROTEIN, HUMAN; SMALL INTERFERING RNA; THROMBOPOIETIN RECEPTOR;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIGEN PURIFICATION; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRIDOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL LINE; GENETICS; IMMUNOLOGY; PROCEDURES;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; MICE; RECEPTORS, THROMBOPOIETIN; RNA, SMALL INTERFERING;

EID: 77952025517     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2009.0095     Document Type: Article

References (22)

1. Battinelli EM, Hartwig JH, and Italiano JE Jr: Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol 2007;14:419-426.
2. Deutsch VR, and Tomer A: Megakaryocyte development and platelet production. Br J Haematol 2006;134:453-466.
3. Kaushansky K: The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005;115:3339-3347.
4. Boulay JL, O'Shea JJ, and Paul WE: Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003;19:159-163.
5. Kaushansky K, and Drachman JG: The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002;21:3359-3367.
6. Sabath DF, Kaushansky K, and Broudy VC: Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. Blood 1999;94:365-367.
7. Morita H, Tahara T, Matsumoto A, Kato T, Miyazaki H, and Ohashi H: Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Lett 1996;395:228-234.
8. Luoh SM, Stefanich E, Solar G, Steinmetz H, Lipari T, Pestina TI, Jackson CW, and de Sauvage FJ: Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo. Mol Cell Biol 2000;20:507-515.
9. Tong W, Sulahian R, Gross AW, Hendon N, Lodish HF, and Huang LJ: The membrane-proximal region of the thrombopoietin receptor confers its high surface expression by JAK2-dependent and-independent mechanisms. J Biol Chem 2006;281:38930-38940.
10. Methia N, Louache F, Vainchenker W, and Wendling F: Oligodeoxynucleotides antisense to the proto-oncogene cmpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993;82:1395-1401.
11. Graf G, Dehmel U, and Drexler HG: Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines. Leuk Res 1996;20:831-838.
12. Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, and Eaton DL: Role of c-mpl in early hematopoiesis. Blood 1998;92:4-10.
13. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, and Methia N: The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391-401.
14. Deng B, Banu N, Malloy B, Hass P, Wang JF, Cavacini L, Eaton D, and Avraham H: An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis. Blood 1998;92:1981-1988.
15. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang HS, Samal B, Nichol JL, Swift S, et al: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
16. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbone WC, Henzel WJ, Wong SC, Kuang WJ, et al: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
17. Wei P, Zhan J, Liu S, Chang D, Haldankar R, Burkhardt K, Li M, and Zhang Y: Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor. Hybridoma 2006;25:115-124. (Pubitemid 43967696)
18. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, et al: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996;87:2154-2161.
19. Li J, Xia Y, and Kuter DJ: Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Br J Haematol 1999;106:345-356.
20. Kirkpatrick P: Specificity concerns with antibodies for receptor mapping. Nat Rev Drug Discov 2009;8:278.
21. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, um M, Van G, and Begley CG: Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 2006;107:1892-1895. (Pubitemid 43289368)
22. Beullens M, Delanghe JR, and Bollen M: False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood 2006;107:4711-4713.